← Back to Search

Molecular Diagnostic Test

Rectal swab collection for Enterobacteriaceae

N/A
Waitlist Available
Research Sponsored by Meridian Bioscience, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial will compare a new test for detecting Carbapenemase Producing Organisms (CPOs) to the current standard method.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance characteristics : Clinical sensitivity (true positive rate) in comparison to the Reference Method
Performance characteristics : clinical specificity (true negative rate) in comparison to the Reference Method

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: revogene TestingExperimental Treatment1 Intervention
The swab will be used for the testing on the revogene using the GenePOC Carba assay.
Group II: Reference MethodActive Control1 Intervention
The other swab will be used in the Reference Method.

Find a Location

Who is running the clinical trial?

Meridian Bioscience, Inc.Lead Sponsor
32 Previous Clinical Trials
11,549 Total Patients Enrolled
Keith Chiasson, PhDStudy DirectorMeridian Bioscience, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings for participants in this research experiment?

"The clinical trial database maintained by clinicialtrials.gov attests that this medical study is not presently seeking out any more participants; the initial entry was made on February 12th, 2019 and last updated April 29th 2021. Nevertheless, there are 1 other studies actively enrolling patients at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.
2019. "Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03680898.
~195 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top